Skip to main content

MoneyWorks4Me

Vista Pharma informs about outcome of board meeting

24 Feb 2018 Evaluate

With reference to the subject cited, it is hereby informed that the Board of Directors of Vista Pharma at the meeting held on February 24, 2018 at the Corporate office of the Company, considered and approved the appointment of Chakravarthula Divya Bhavani, as Additional Director (Non- Executive, Independent) on the Board of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1886.80
Dr. Reddys Labs. 1386.00
Cipla 1410.00
Lupin 2014.00
Zydus Lifesciences 1205.50
View more..